154 related articles for article (PubMed ID: 21233446)
21. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer.
Huang Y; Zhang J; Cui ZM; Zhao J; Zheng Y
Chin J Cancer; 2013 May; 32(5):289-96. PubMed ID: 22958742
[TBL] [Abstract][Full Text] [Related]
22. Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K/BxN serum-induced arthritis.
Isozaki T; Arbab AS; Haas CS; Amin MA; Arendt MD; Koch AE; Ruth JH
Arthritis Rheum; 2013 Jul; 65(7):1736-46. PubMed ID: 23633118
[TBL] [Abstract][Full Text] [Related]
23. The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion.
Koenen A; Babendreyer A; Schumacher J; Pasqualon T; Schwarz N; Seifert A; Deupi X; Ludwig A; Dreymueller D
PLoS One; 2017; 12(3):e0173486. PubMed ID: 28267793
[TBL] [Abstract][Full Text] [Related]
24. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
Sawada S; Harada K; Isse K; Sato Y; Sasaki M; Kaizaki Y; Nakanuma Y
Pathol Int; 2007 Oct; 57(10):652-63. PubMed ID: 17803654
[TBL] [Abstract][Full Text] [Related]
25. Plasmacytoid dendritic cell response to CpG ODN correlates with CXCL16 expression and is inhibited by ox-LDL.
Gursel M; Klinman DM; Gursel I
Mediators Inflamm; 2013; 2013():312590. PubMed ID: 24302814
[TBL] [Abstract][Full Text] [Related]
26. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis.
Takiguchi G; Nishita M; Kurita K; Kakeji Y; Minami Y
Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384
[TBL] [Abstract][Full Text] [Related]
27. [Role of CXCL16/CXCR6 axis in the metastasis of human prostate cancer].
Zhou WH; Hu WD; Wu ZQ; Zheng XM; Wang BC
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):947-51. PubMed ID: 20646641
[TBL] [Abstract][Full Text] [Related]
28. Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells.
Tabata S; Kadowaki N; Kitawaki T; Shimaoka T; Yonehara S; Yoshie O; Uchiyama T
J Leukoc Biol; 2005 May; 77(5):777-86. PubMed ID: 15703197
[TBL] [Abstract][Full Text] [Related]
29. Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID.
Scott NA; Pearmain L; Knight SB; Brand O; Morgan DJ; Jagger C; Harbach S; Khan S; Shuwa HA; Franklin M; Kästele V; Williams T; Prise I; McClure FA; Hackney P; Smith L; Menon M; Konkel JE; Lawless C; Wilson J; Mathioudakis AG; Stanel SC; Ustianowski A; Lindergard G; Brij S; Diar Bakerly N; Dark P; Brightling C; Rivera-Ortega P; Lord GM; Horsley A; ; Piper Hanley K; Felton T; Simpson A; Grainger JR; Hussell T; Mann ER
Eur Respir J; 2023 May; 61(5):. PubMed ID: 36922030
[TBL] [Abstract][Full Text] [Related]
30. SR-PSOX at sites predisposed to atherosclerotic lesion formation mediates monocyte-endothelial cell adhesion.
Hofnagel O; Engel T; Severs NJ; Robenek H; Buers I
Atherosclerosis; 2011 Aug; 217(2):371-8. PubMed ID: 21612780
[TBL] [Abstract][Full Text] [Related]
31. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas.
Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J
Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614
[TBL] [Abstract][Full Text] [Related]
32. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance.
Jiang X; Shimaoka T; Kojo S; Harada M; Watarai H; Wakao H; Ohkohchi N; Yonehara S; Taniguchi M; Seino K
J Immunol; 2005 Aug; 175(4):2051-5. PubMed ID: 16081769
[TBL] [Abstract][Full Text] [Related]
33. The CXCL16-CXCR6 chemokine axis in glial tumors.
Hattermann K; Held-Feindt J; Ludwig A; Mentlein R
J Neuroimmunol; 2013 Jul; 260(1-2):47-54. PubMed ID: 23628207
[TBL] [Abstract][Full Text] [Related]
34. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis.
Aslanian AM; Charo IF
Circulation; 2006 Aug; 114(6):583-90. PubMed ID: 16880330
[TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer.
Richardsen E; Ness N; Melbø-Jørgensen C; Johannesen C; Grindstad T; Nordbakken C; Al-Saad S; Andersen S; Dønnem T; Nordby Y; Bremnes RM; Busund LT
Am J Pathol; 2015 Oct; 185(10):2722-30. PubMed ID: 26272362
[TBL] [Abstract][Full Text] [Related]
36. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
Gutwein P; Schramme A; Sinke N; Abdel-Bakky MS; Voss B; Obermüller N; Doberstein K; Koziolek M; Fritzsche F; Johannsen M; Jung K; Schaider H; Altevogt P; Ludwig A; Pfeilschifter J; Kristiansen G
Eur J Cancer; 2009 Feb; 45(3):478-89. PubMed ID: 19070478
[TBL] [Abstract][Full Text] [Related]
37. Escin suppresses migration and invasion involving the alteration of CXCL16/CXCR6 axis in human gastric adenocarcinoma AGS cells.
Lee HS; Hong JE; Kim EJ; Kim SH
Nutr Cancer; 2014; 66(6):938-45. PubMed ID: 24911042
[TBL] [Abstract][Full Text] [Related]
38. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.
Hu W; Zhen X; Xiong B; Wang B; Zhang W; Zhou W
Cancer Sci; 2008 Jul; 99(7):1362-9. PubMed ID: 18452560
[TBL] [Abstract][Full Text] [Related]
39. CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.
Gutwein P; Abdel-Bakky MS; Schramme A; Doberstein K; Kämpfer-Kolb N; Amann K; Hauser IA; Obermüller N; Bartel C; Abdel-Aziz AA; El Sayed el SM; Pfeilschifter J
Am J Pathol; 2009 Jun; 174(6):2061-72. PubMed ID: 19435795
[TBL] [Abstract][Full Text] [Related]
40. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines.
Wilbanks A; Zondlo SC; Murphy K; Mak S; Soler D; Langdon P; Andrew DP; Wu L; Briskin M
J Immunol; 2001 Apr; 166(8):5145-54. PubMed ID: 11290797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
